How much do I need in an ISA to generate a £500 monthly second income?

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together

It’s fairly easy to build a tax-free second income. For me, the simplest route is investing in a portfolio of UK shares through a Stocks and Shares ISA.

Top FTSE 100 and FTSE 250 companies don’t just offer the chance of share price growth, they also pay regular dividends, rewarding investors even in years when the shares struggle. Reinvest those dividends and the total return can compound into a sizeable income over time.

It’s not essential to use shares, of course. A Cash ISA can currently pay around 4% a year, with no risk to capital. That’s attractive, especially for short-term savings. But is it attractive enough?

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Stocks and shares options

Let’s say someone wants to generate a second income of £500 a month, or £6,000 a year. At a 4% return, they’d need a nest egg of roughly £150,000. Perfectly achievable, but it means missing out on the higher long-term returns shares have historically delivered. Over time, the FTSE 100’s generated average annual returns closer to 8%, combining share price growth with reinvested dividends.

The difference is striking. Someone saving £250 a month into a Cash ISA paying 4% would reach £150,000 in just under 28 years. Invest the same amount into a share portfolio returning 8%, and they’d get there in just over 20 years, eight years sooner.

Carry on investing for the full 28 years and the shares would be worth more than £300,000, double the size of the cash pot. The real benefits of buying equities that compound and grow over time.

Many new equity investors keep things simple by buying a tracker fund, perhaps following the FTSE 100, the US market, or a global index of shares. That’s a perfectly sensible approach.

At The Motley Fool though, we favour building a diversified portfolio of individual UK stocks. Done well, this can generate higher dividend income and stronger long-term growth. Stock-picking is more hands-on though, and comes with more risk.

GSK share price finally rises

One FTSE 100 stock worth considering is GSK (LSE: GSK). The pharmaceuticals and vaccines giant has endured a difficult decade, as it worked to replace blockbuster drugs that had gone off patent. Developing new treatments is slow, expensive and risky, with tough regulatory hurdles along the way.

GSK was once famed for its dividend, but payouts were frozen for years as cash was funnelled into rebuilding the pipeline. Now the hard work appears to be paying off. The share price has jumped 50% in the past 12 months.

I bought the stock 18 months ago as a recovery play, and after an early dip, my patience is finally being rewarded. GSK doesn’t look expensive, with a price-to-earnings ratio of about 12.5. The trailing dividend yield is a modest 3%, but there’s scope for growth over time. There are still risks. The GSK share price may slow after the recent strong run. It needs to keep working on that pipeline, to boost revenues and margins. But I think it’s well worth considering with a long-term view.

Dividend shares can be far more rewarding than cash over the long term, but investors must be willing to stay patient and ride out the bumps along the way.

The post How much do I need in an ISA to generate a £500 monthly second income? appeared first on The Motley Fool UK.

Should you invest £1,000 in GSK right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if GSK made the list?

More reading

Harvey Jones has positions in GSK. The Motley Fool UK has recommended GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.